Abstract
Although pectin oligosaccharide (POS) can inhibit the growth and proliferation of gastric, colon, prostate, breast, melanoma, and leukemia cells, its effect on bladder cancer remains unknown. Therefore, screening and identification of factors associated with the sensitivity of bladder cancer to drugs and elucidation of their molecular mechanisms will help provide a theoretical basis for establishing postoperative systemic chemotherapy for patients with bladder cancer. We showed that POS promoted the apoptosis of bladder cancer cells, and this finding was consistent with enhanced α2,6-sialylation post-modification. Moreover, POS activated the Hedgehog pathway, the inhibition of which regulated the tumorigenicity of bladder cancer cells in vivo. These findings were consistent with our results in vitro. We conclude that POS promotes the apoptosis of bladder cancer and offers new insights and evidence for the development of individualized treatment strategies. Schema of molecular events underlying POS-induced inhibition of bladder cancer cell proliferation.
Similar content being viewed by others
Data Availability
Data are included in the article and in supplementary information.
Abbreviations
- IHC:
-
immunohistochemical analysis
- POS:
-
pectin oligosaccharide
- SA:
-
sialic acid
- ST:
-
sialyltransferase
- ST6Gal-1:
-
β-galactoside α2,6-sialyltransferase 1
References
Ferlay, J., et al. (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer, 136(5), E359–E386.
Pang, C., et al. (2016). Urologic cancer in China. Japanese Journal of Clinical Oncology, 46(6), 497–501.
Chamie, K., et al. (2013). Recurrence of high‐risk bladder cancer: a population‐based analysis. Cancer, 119(17), 3219–3227.
Pietzak, E. J., et al. (2017). Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets. European Urology, 72(6), 952–959.
Natoni, A., Macauley, M. S., & O’Dwyer, M. E. (2016). Targeting selectins and their ligands in cancer. Frontiers in Oncology, 6, 93.
Bhide, G. P., & Colley, K. J. (2017). Sialylation of N-glycans: mechanism, cellular compartmentalization and function. Histochemistry and Cell Biology, 147(2), 149–174.
Büll, C., et al. (2014). Sialic acids sweeten a tumor’s life. Cancer Research, 74(12), 3199–3204.
Büll, C., et al. (2016). Sialic acid mimetics to target the sialic acid–Siglec axis. Trends in Biochemical Sciences, 41(6), 519–531.
Du, J., et al. (2009). Metabolic glycoengineering: sialic acid and beyond. Glycobiology, 19(12), 1382–1401.
Schultz, M. J., et al. (2016). The tumor-associated glycosyltransferase ST6Gal-I regulates stem cell transcription factors and confers a cancer stem cell phenotype. Cancer Research, 76(13), 3978–3988.
Antony, P., et al. (2014). Epigenetic inactivation of ST6GAL1 in human bladder cancer. BMC Cancer, 14(1), 1–11.
Swindall, A. F., et al. (2013). ST6Gal-I protein expression is upregulated in human epithelial tumors and correlates with stem cell markers in normal tissues and colon cancer cell lines. Cancer Research, 73(7), 2368–2378.
Zhao, Y., et al. (2020). alpha 2, 6-Sialylation mediates hepatocellular carcinoma growth in vitro and in vivo by targeting the Wnt/beta-catenin pathway (Retraction of Vol 6, art no E343, 2017). New York, NY: Nature Publishing Group.
Wei, A., et al. (2016). ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway. Oncotarget, 7(40), 65374.
Lu, J., & Gu, J. (2015). Significance of β-galactoside α2, 6 sialyltranferase 1 in cancers. Molecules, 20(5), 7509–7527.
Tan, H., Chen, W., & Liu, Q., et al. (2018). Pectin oligosaccharides ameliorate colon cancer by regulating oxidative stress- and inflammation-activated signaling pathways. Frontiers in Immunology, 9, 1504.
Wan, J., Zhang, X. C., Neece, D., Ramonell, K. M., Clough, S., & Kim, S. Y. et al. (2008). LysM receptor-like kinase plays a critical role in chitin signaling and fungal resistance in Arabidopsis. Plant Cell, 20(2), 471–481.
Olano-Martin, E., et al. (2003). Pectin and pectic-oligosaccharides induce apoptosis in in vitro human colonic adenocarcinoma cells. Anticancer Research, 23(1A), 341–346.
Nishida, M., et al. (2014). Pectin of Prunus domestica L. alters sulfated structure of cell-surface heparan sulfate in differentiated Caco-2 cells through stimulation of heparan sulfate 6-O-endosulfatase-2. Bioscience, Biotechnology, and Biochemistry, 78(4), 635–643.
Tan, H., et al. (2018). Pectin oligosaccharides ameliorate colon cancer by regulating oxidative stress-and inflammation-activated signaling pathways. Frontiers in Immunology, 9, 1504.
Sibiya, N., Ngubane, P., & Mabandla, M. (2017). Cardio-protective effects of pectin-insulin patch in streptozotocin-induced diabetic rats beneficial effects of insulin patch. Journal of Diabetes, 9(12), 1073–1081.
Gao, W., et al. (2016). Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitors. Annals of the Rheumatic Diseases, 75(1), 311–315.
Davidson, L. A., et al. (1995). Dietary fat and fiber alter rat colonic protein kinase C isozyme expression. The Journal of Nutrition, 125(1), 49–56.
Sakhalkar, S. P., Patterson, E. B., & Khan, M. M. (2005). Involvement of histamine H1 and H2 receptors in the regulation of STAT-1 phosphorylation: inverse agonism exhibited by the receptor antagonists. International Immunopharmacology, 5(7-8), 1299–1309.
Chen, C.-H., et al. (2006). Suppression of endotoxin-induced proinflammatory responses by citrus pectin through blocking LPS signaling pathways. Biochemical Pharmacology, 72(8), 1001–1009.
Kubo, M., et al. (2004). Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer. Cancer Research, 64(17), 6071–6074.
Mazumdar, T., et al. (2011). The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancer. Oncotarget, 2(8), 638.
Wang, J., et al. (2017). GLI2 induces PDGFRB expression and modulates cancer stem cell properties of gastric cancer. European Review for Medical and Pharmacological Sciences, 21(17), 3857–3865.
Yang, H., et al. (2019). lncRNA BCAR4 increases viability, invasion, and migration of non-small cell lung cancer cells by targeting glioma-associated oncogene 2 (GLI2). Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 27(3), 359–369.
Cheng, W.-T., et al. (2009). Role of Hedgehog signaling pathway in proliferation and invasiveness of hepatocellular carcinoma cells. International Journal of Oncology, 34(3), 829–836.
Acknowledgements
This study was approved by Research Project of Liaoning Provincial Department of Education (No. JYTQN2020037).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Ethical Approval
All animal care and experiments proceeded in accordance with our Institutional Animal Care protocols. All animal experiments complied with the guidelines outlined by the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Huang, Y., Wang, T. Pectin Oligosaccharides Enhance α2,6-Sialylation Modification that Promotes Apoptosis of Bladder Cancer Cells by Targeting the Hedgehog Pathway. Cell Biochem Biophys 79, 719–728 (2021). https://doi.org/10.1007/s12013-021-00996-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-021-00996-9